Fluconazole Dosing for Surgical Site Candidiasis

Initial Dosing Strategy

The Infectious Diseases Society of America recommends administering a loading dose of 800 mg (12 mg/kg) on Day 1, followed by 400 mg (6 mg/kg) daily for invasive candidiasis, which includes surgical site infections 3, 4
The primary recommendation for most invasive Candida infections, including surgical site involvement, is 400 mg (6 mg/kg) daily 1, 2, 5

For C. glabrata (fluconazole-resistant), the Infectious Diseases Society of America recommends switching to amphotericin B deoxycholate 0.3-0.6 mg/kg daily or an echinocandin 1, 2
For C. krusei, the Infectious Diseases Society of America recommends not using fluconazole; instead, use amphotericin B or an echinocandin as this species has intrinsic resistance 1, 2

The minimum treatment duration is at least 2 weeks after documented clearance of Candida from blood cultures if candidemia is present 3, 4
The minimum total treatment duration is 2-4 weeks for uncomplicated surgical site infections without candidemia 1, 2

Surgical debridement is essential for infected surgical sites with necrotic tissue or abscesses, according to the Infectious Diseases Society of America 1, 2
Removing all foreign bodies, including drains, mesh, or other prosthetic materials, is recommended when feasible 1, 2
Removing or replacing central venous catheters is recommended if candidemia is documented 3, 4

The Infectious Diseases Society of America advises against using fluconazole empirically without considering local resistance patterns and prior antifungal exposure 3, 4
The Infectious Diseases Society of America recommends obtaining susceptibility testing to guide definitive therapy, especially for non-albicans species 1, 2
The Infectious Diseases Society of America advises against using fluconazole for C. krusei as it has intrinsic resistance 1, 2
The Infectious Diseases Society of America emphasizes the importance of source control, as antifungals alone are insufficient without surgical management 1, 2